Your state · Dedicated state pack
Addiction treatment marketing rules in New Jersey
What you can claim, how you can pay for referrals, and where New Jersey diverges from the federal floor. Derived from the live ruleset library.
Yes. New Jersey has its own addiction-treatment marketing law, and Pre-Trip carries it as a live, human-reviewed ruleset, last verified 2026-07-23. On top of the federal floor that applies everywhere (EKRA, 42 CFR Part 2, and the FTC Act), New Jersey adds state-specific limits on what you can claim and how you can pay for referrals. A clean pass here means the copy cleared both layers.
N.J.S.A. 2C:40A-6 (patient brokering, as amended by P.L. 2025 c.121 / A3973, signed and effective Aug 11 2025; a third-degree crime carrying a fixed $50,000 criminal fine plus restitution, and a civil
Every New Jersey scan also runs the always-on federal layer: 42 CFR Part 2 confidentiality and FTC endorsement rules in addic, Platform certification requirements for addiction treatment adve, EKRA referral remuneration in marketing copy, FTC deceptive health claims and endorsements. A ruleset counts toward a clean pass only while it is published, matches its content hash, and its review clock is fresh, which is why the date above is load-bearing.
The claim types New Jersey law puts off-limits in treatment marketing. Each is compiled from the cited section; the scanner reads your copy for them, and the patterns stay on the server.
-
High riskPromises of cure or guarantees of treatment success for substance use disorder.
A promise of cure or a guarantee of treatment success for substance use disorder is a false or misleading statement about the substance use disorder services offered, an unlawful practice under A3974, N.J.S.A. 56:8-230 to 56:8-232 (unlawful practice (5), false statement about substance use disorder services), which carries a civil penalty up to $20,000 per violation under the Penalty Enforcement Law plus a private right of action and treble damages. Because such a claim also operates as an inducement to a patient to use a provider's services, it can implicate the patient-brokering bar at N.J.S.A. 2C:40A-6, a third-degree crime. New Jersey has no information-services exception of the Florida kind, so the mapping to the deceptive-marketing false-statement practice is a reviewer confirmation item.
N.J.S.A. 56:8-230 to 56:8-232 (P.L. 2025 c.122, A3974), unlawful practice (5) (false substance use disorder services statement), https://pub.njleg.gov/Bills/2024/AL25/122_.HTM
-
High riskOffers of free or covered travel, airfare, lodging, or scholarship beds as an inducement to enter treatment.
Offers of free or covered travel, airfare, lodging, or scholarship beds are things of value given, directly or indirectly and in cash or in kind, to induce a patient to use a provider's services, the core of the patient-brokering prohibition at N.J.S.A. 2C:40A-6 as amended by P.L. 2025 c.121. A violation is a third-degree crime carrying a fixed $50,000 criminal fine plus restitution, and a civil penalty up to $20,000 per violation (assessed by the Department of Health as to licensed facilities and clinical laboratories, and by the Division of Consumer Affairs as to recovery residences).
N.J.S.A. 2C:40A-6 (P.L. 2025 c.121, A3973), https://pub.njleg.gov/Bills/2024/AL25/121_.HTM
-
High riskOffering to provide or arrange transportation to treatment or admission.
Providing or arranging transportation to treatment or admission is a thing of value given in kind to induce a patient to use a provider's services, prohibited by the patient-brokering bar at N.J.S.A. 2C:40A-6 as amended by P.L. 2025 c.121. A violation is a third-degree crime carrying a fixed $50,000 criminal fine plus restitution, and a civil penalty up to $20,000 per violation (Department of Health as to licensed facilities and clinical laboratories, Division of Consumer Affairs as to recovery residences).
N.J.S.A. 2C:40A-6 (P.L. 2025 c.121, A3973), https://pub.njleg.gov/Bills/2024/AL25/121_.HTM
-
FlagA directory, helpline, or placement service describing itself as independent, unbiased, or neutral in copy that routes callers to treatment providers.
A3974 makes it an unlawful practice to provide false or misleading website information or to surreptitiously redirect a prospective patient to a different provider (N.J.S.A. 56:8-230 to 56:8-232, unlawful practice (3)). A placement or referral service that markets itself as independent, unbiased, or neutral while routing callers to fee-paying providers is the copy-visible face of that practice. The rule can only see the independence claim in copy, not the actual redirect behavior. Civil penalty up to $20,000 per violation, plus a private right of action and treble damages; enforced by the Department of Health and the Division of Consumer Affairs.
N.J.S.A. 56:8-230 to 56:8-232 (P.L. 2025 c.122, A3974), unlawful practice (3) (false website or surreptitious redirect), https://pub.njleg.gov/Bills/2024/AL25/122_.HTM
-
FlagBlanket claims that a provider is in-network with all, any, or every insurer, or guaranteed or always in-network.
A3974 makes a false statement about a provider's in-network or out-of-network insurance status an unlawful practice (N.J.S.A. 56:8-230 to 56:8-232, unlawful practice (1)). A blanket claim of being in-network with all, any, or every insurer is the copy shape most likely to be false; the scanner cannot verify actual network status from copy, so this is surfaced for verification rather than asserted as a violation. Civil penalty up to $20,000 per violation, plus a private right of action and treble damages.
N.J.S.A. 56:8-230 to 56:8-232 (P.L. 2025 c.122, A3974), unlawful practice (1) (false in-network or out-of-network status), https://pub.njleg.gov/Bills/2024/AL25/122_.HTM
-
FlagCopy implying government endorsement or official state or agency affiliation of a treatment provider, for example state-endorsed, government-backed, or official provider of a named agency.
A3974 makes an implied affiliation asserted without express written consent an unlawful practice (N.J.S.A. 56:8-230 to 56:8-232, unlawful practice (4)). Copy implying government endorsement or official state or agency approval of a treatment provider is the clearest deceptive variant of that practice and cannot be substantiated from copy, so it is surfaced for verification. Civil penalty up to $20,000 per violation, plus a private right of action and treble damages.
N.J.S.A. 56:8-230 to 56:8-232 (P.L. 2025 c.122, A3974), unlawful practice (4) (implied affiliation without express written consent), https://pub.njleg.gov/Bills/2024/AL25/122_.HTM
The exposure New Jersey attaches to a marketing violation, by tier. Exact amounts and elements live in the cited statute.
- CriminalPatient-brokering or referral-payment conduct can carry criminal exposure. The tier is in the cited statute.
- CivilCivil penalties per violation and deceptive-practices exposure. Amounts are in the cited section.
- LicenseAdvertising violations can trigger license discipline for the facility or the provider.
What the scanner does with two versions of the same idea. The flagged line is rendered the way Pre-Trip renders a finding; the clean line is a pass.
Our program guarantees your recovery from addiction, for good.
A promise of cure or a guaranteed outcome for substance use disorder. Outcomes cannot be guaranteed, and the claim is unsubstantiated on its face.
Cure and guarantee claims · N.J.S.A. 2C:40A-6 (patient brokering, P.L. 2025 c.121 / A3973)
Our program gives people the tools and the support to build lasting recovery.
Describes the service and the support without promising a guaranteed result.
Compensation for marketers, recruiters, or referral partners described as paid per admission, per patient, per referral, or per placement, or otherwise conditioned on the volume or value of patients delivered.. In New Jersey, N.J.S.A. 2C:40A-6 (as amended by P.L. 2025, c.121) makes referral remuneration for SUD facilities, recovery residences, and clinical laboratories a third-degree crime carrying a $50,000 fine plus restitution, and it reaches payment in exchange for a patient using services, not only referrals; civil penalties run up to $20,000 per violation.
18 U.S.C. 220 makes paying or receiving remuneration for referrals to recovery homes, clinical treatment facilities, or labs a federal crime, up to $200,000 and 10 years per occurrence, and labeling t
New Jersey and federal sources
- N.J.S.A. 2C:40A-6 (patient brokering, P.L. 2025 c.121 / A3973) primary
- N.J.S.A. 56:8-230 to 56:8-232 (deceptive substance use disorder treatment marketing, P.L. 2025 c.122 / A3974) primary
- 42 C.F.R. Part 2 (eCFR current text) primary
- 16 C.F.R. Part 255 Endorsement Guides primary
- HHS fact sheet, 42 CFR Part 2 Final Rule (2024)
- 15 U.S.C. 45d (OARFPA 2018) primary
- Google Ads Healthcare and medicines policy primary
- Meta advertising standards, addiction treatment primary
- LegitScript addiction treatment certification
Pre-Trip is a rigorous screen, not legal advice. Counsel decides; we help you arrive prepared. Coverage for New Jersey reflects the library as of the build and changes as the law does.